256 related articles for article (PubMed ID: 23558378)
1. Biological therapies for rheumatoid arthritis: progress to date.
Malviya G; Salemi S; Laganà B; Diamanti AP; D'Amelio R; Signore A
BioDrugs; 2013 Aug; 27(4):329-45. PubMed ID: 23558378
[TBL] [Abstract][Full Text] [Related]
2. Therapeutic strategies in psoriasis patients with psoriatic arthritis: focus on new agents.
Gan EY; Chong WS; Tey HL
BioDrugs; 2013 Aug; 27(4):359-73. PubMed ID: 23580094
[TBL] [Abstract][Full Text] [Related]
3. Comparative overview of safety of the biologics in rheumatoid arthritis.
Khraishi M
J Rheumatol Suppl; 2009 Jun; 82():25-32. PubMed ID: 19509327
[TBL] [Abstract][Full Text] [Related]
4. Tumour necrosis factor α antagonists in the treatment of rheumatoid arthritis: an immunological perspective.
Meroni PL; Valesini G
BioDrugs; 2014 Apr; 28 Suppl 1():S5-13. PubMed ID: 24687234
[TBL] [Abstract][Full Text] [Related]
5. New therapeutic options in rheumatoid arthritis: a focus on interleukin-6 blockade.
Furfaro N
J Infus Nurs; 2011; 34(2):107-15. PubMed ID: 21399456
[TBL] [Abstract][Full Text] [Related]
6. Treatment of rheumatoid arthritis: Unraveling the conundrum.
Zampeli E; Vlachoyiannopoulos PG; Tzioufas AG
J Autoimmun; 2015 Dec; 65():1-18. PubMed ID: 26515757
[TBL] [Abstract][Full Text] [Related]
7. Investigational agents for rheumatoid arthritis.
Merkel PA; Letourneau EN; Polisson RP
Rheum Dis Clin North Am; 1995 Aug; 21(3):779-96. PubMed ID: 8619099
[TBL] [Abstract][Full Text] [Related]
8. The efficacy and tolerability of newer biologics in rheumatoid arthritis: best current evidence.
Siddiqui MA
Curr Opin Rheumatol; 2007 May; 19(3):308-13. PubMed ID: 17414961
[TBL] [Abstract][Full Text] [Related]
9. Vitaxin applied molecular evolution.
Mikecz K
Curr Opin Investig Drugs; 2000 Oct; 1(2):199-203. PubMed ID: 11249574
[TBL] [Abstract][Full Text] [Related]
10. [New biological therapeutic options for the treatment of RE: inhibition of costimulatory molecules and blockade of Interleukin-6-interaction].
Perniok A; Rubbert-Roth A
Z Rheumatol; 2003 Oct; 62(5):433-8. PubMed ID: 14579030
[TBL] [Abstract][Full Text] [Related]
11. Use of biologics in rheumatoid arthritis: where are we going?
Pucino F; Harbus PT; Goldbach-Mansky R
Am J Health Syst Pharm; 2006 Sep; 63(18 Suppl 4):S19-41. PubMed ID: 16960244
[TBL] [Abstract][Full Text] [Related]
12. Future use of biologic agents alone and in combination for the treatment of rheumatoid arthritis.
Strand V
Z Rheumatol; 1998 Feb; 57(1):41-5. PubMed ID: 9566107
[No Abstract] [Full Text] [Related]
13. Novel therapies for rheumatoid arthritis.
Tremoulet AH; Albani S
Expert Opin Investig Drugs; 2006 Nov; 15(11):1427-41. PubMed ID: 17040201
[TBL] [Abstract][Full Text] [Related]
14. Room for more IL-6 blockade? Sarilumab for the treatment of rheumatoid arthritis.
June RR; Olsen NJ
Expert Opin Biol Ther; 2016 Oct; 16(10):1303-9. PubMed ID: 27464017
[TBL] [Abstract][Full Text] [Related]
15. New therapeutic approaches in rheumatoid arthritis.
van Vollenhoven RF
Presse Med; 2016 Jun; 45(6 Pt 2):e179-92. PubMed ID: 27242206
[TBL] [Abstract][Full Text] [Related]
16. Joint damage progression in patients with rheumatoid arthritis in clinical remission: do biologics perform better than synthetic antirheumatic drugs?
Ciubotariu E; Gabay C; Finckh A;
J Rheumatol; 2014 Aug; 41(8):1576-82. PubMed ID: 25028383
[TBL] [Abstract][Full Text] [Related]
17. Targeting IL-6 for the treatment of rheumatoid arthritis: Phase II investigational drugs.
Semerano L; Thiolat A; Minichiello E; Clavel G; Bessis N; Boissier MC
Expert Opin Investig Drugs; 2014 Jul; 23(7):979-99. PubMed ID: 24766460
[TBL] [Abstract][Full Text] [Related]
18. Successful rapid rituximab desensitization for hypersensitivity reactions to monoclonal antibodies in a patient with rheumatoid arthritis: a remarkable option.
Abadoglu O; Epozturk K; Atayik E; Kaptanoglu E
J Investig Allergol Clin Immunol; 2011; 21(4):319-21. PubMed ID: 21721382
[No Abstract] [Full Text] [Related]
19. [Targeting CD20 in rheumatoid arthritis].
Saito K; Tanaka Y
Nihon Rinsho; 2007 Jul; 65(7):1243-9. PubMed ID: 17642239
[TBL] [Abstract][Full Text] [Related]
20. The trials of anakinra.
Burls A; Jobanputra P
Lancet; 2004 Sep 4-10; 364(9437):827-8. PubMed ID: 15351176
[No Abstract] [Full Text] [Related]
[Next] [New Search]